Microbix Biosystems Inc. (TSX:MBX)

Market Cap	41.47M
Revenue (ttm)	22.72M
Net Income (ttm)	1.56M
Shares Out	140.56M
EPS (ttm)	0.01
PE Ratio	26.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	104,873
Average Volume	68,918
Open	0.2950
Previous Close	0.2950
Day's Range	0.2900 - 0.2950
52-Week Range	0.2800 - 0.5500
Beta	0.24
RSI	41.89
Earnings Date	Aug 11, 2025

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. I...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 70
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX